PCOS Oily Skin vs. Dry Skin: The Sebum-Versus-Hydration Split

Does PCOS actually cause oily skin?

For a documented majority, yes, but “PCOS equals oily skin” is an overstatement that skincare content repeats far more confidently than the evidence supports. This is one entry in a wider set of skin and hair changes PCOS can cause, and it deserves its own page precisely because most coverage treats it as settled rather than variable. A cross-sectional study of 40 women with PCOS found seborrhea — visibly oily skin from excess sebum — in 52.5% of participants, alongside the jawline-clustered acne pattern PCOS causes in 67.5% and hirsutism in 62.5%. That means in this study, just under half of the women with PCOS did not present with clinically oily skin, despite sharing the same diagnosis and, presumably, a broadly similar hormonal profile on paper. The mechanism behind the majority who do get oily skin is well established: androgens act directly on the sebaceous gland attached to each hair follicle, and androgen-driven sebum production is a required step in acne’s development, which is why oily skin and hormonal acne track together so closely in the studies that measure both. What is less often said is that the size of this effect tracks how much biochemically measurable androgen excess a person actually has, and PCOS is diagnosed on a mix of criteria — irregular ovulation, polycystic ovarian morphology, or hyperandrogenism, any two of three under the Rotterdam definition — so two people can carry the same diagnosis while one has substantially higher circulating androgens than the other. A milder or non-hyperandrogenic phenotype has correspondingly less reason to produce visibly oily skin, and pages that treat “PCOS skin” as one uniform outcome are describing the majority pattern as though it were universal.

What is the actual difference between oily and dehydrated skin?

Oily and dehydrated describe two different things your skin can be short on or overproducing, and conflating them is the single most common reason a skincare routine backfires. Oily is a sebum state: the sebaceous glands are producing more of the oily, waxy substance that sits on the skin’s surface and lines the follicle. Dehydrated is a water state: the outermost skin layer is short on water content, regardless of how much oil is present. Sebum itself plays a real role in retaining water at the skin’s surface, which is exactly why the two states are not opposites — skin can run low on water while still producing plenty of oil, producing a surface that looks shiny in some areas, feels tight or flaky in others, and does not respond well to a routine built for either problem alone.

Why does treating oily skin aggressively sometimes make it worse?

Over-stripping is the specific mechanism that turns straightforwardly oily skin into oily-and- dehydrated skin, and it is a completely different failure from simply not treating oiliness at all. Harsh, high-alcohol toners, strong foaming cleansers used more than once or twice a day, and over-exfoliating all remove surface lipids — including the sebum that would otherwise help the skin hold onto water. The skin barrier’s water-retention function is degraded by that process regardless of how much sebum the glands underneath are still producing, so the visible result is skin that still looks shiny by midday, because the glands were never the problem being solved, while also feeling tight, flaky, or irritated, because the water-retention layer has been stripped away. The instinct this produces — using an even stronger product because the skin still looks oily — repeats the same mechanism and deepens the dehydration without ever reducing the sebum output driving the shine.

How do PCOS treatments change which skin type you actually have?

This is the point most PCOS skincare content skips entirely: several of the medications used to treat PCOS’s hormonal symptoms reduce sebum production as part of how they work, which means a reader’s current skin type may reflect her treatment more than it reflects PCOS itself. Only a small list of interventions actually modulate sebum production — combined oral contraceptives, oral spironolactone, oral isotretinoin, and topical clascoterone — and three of those four are common PCOS prescriptions. A combined pill raises sex hormone-binding globulin, which binds circulating testosterone and lowers the amount reaching the sebaceous gland; a Cochrane review of 31 placebo-controlled trials found this translated into measurably reduced lesion counts across every comparison, the same mechanism that lowers sebum output generally. A combined pill is not appropriate for everyone regardless of its effect on skin — it carries a higher clotting (VTE) risk for anyone with a personal or strong family history of blood clots, is avoided with migraine with aura, and is generally avoided for smokers over 35, so that history is worth raising before starting one for a skin-related reason as much as for any other. Spironolactone works further downstream, blocking the androgen receptor at the follicle directly rather than lowering the hormone reaching it; a 2025 meta-analysis of five placebo-controlled trials found sixfold higher odds of objective acne improvement on spironolactone than placebo, consistent with meaningfully reduced sebum activity at the gland. Spironolactone requires reliable contraception because of a teratogenic risk to a male fetus, and carries a small hyperkalemia risk monitored with occasional blood tests — particularly alongside an ACE inhibitor, an ARB, or regular NSAID use — the full dosing and monitoring picture is covered separately, and what else the combined pill changes beyond acne is worth reading before starting one for a skin-related reason.

Isotretinoin’s effect on sebum is the largest of the group, by a wide margin. A prospective study of 30 patients measured sebum excretion rate before and after a four-month course of isotretinoin and found it reduced by 83% at the end of treatment, remaining 36% below baseline a full year later. That scale of suppression is why isotretinoin clears severe acne so reliably, and it is also why dryness on isotretinoin is not a side reaction to manage around — it is the expected, dose-dependent result of the drug doing exactly what it is meant to do. A clinical review of isotretinoin’s adverse effects describes these mucocutaneous effects as well recognised and generally manageable with a lower dose where tolerated, but they do not disappear on request — chapped lips, dry skin, and dry eyes track the drug’s dose and duration, not a routine you can adjust your way out of while still taking it.

Who this does not help, and what to do instead

If your dryness started after beginning a combined pill, spironolactone, or isotretinoin, a heavier, richer moisturising routine aimed at “PCOS oily skin” will not fix the actual cause and may simply sit on top of skin that needed a different approach from the start — the honest fix here is a lightweight, barrier-supporting routine built for dry or sensitised skin, not a stronger oil-control product carried over from before treatment. This is the same order of escalation the 2023 international evidence-based guideline describes for PCOS-related acne and excess androgen activity generally — topical measures first, a combined pill or spironolactone next, isotretinoin reserved for severe or treatment-resistant cases — and the skin changes covered on this page are a predictable consequence of moving through that sequence, not a separate problem layered on top of it. Conversely, if genuinely oily, acne-prone skin is not responding to an oil-focused routine at all, the driver is more likely to be androgen activity that a topical product cannot reach, and that is a conversation about the treatments above rather than about finding a stronger cleanser. And if your skin changed suddenly, dramatically, or alongside other new symptoms — unrelated to starting or stopping any medication — this article’s mechanism does not cover that pattern, and it is worth having examined directly rather than assumed to be PCOS. Darkened patches, itching, and acanthosis nigricans are separate presentations with their own drivers, and the fuller map of PCOS skin changes beyond oiliness and dryness is worth reading if any of those also apply to you.

You may also see this condition referred to as polyendocrine metabolic ovarian syndrome (PMOS) after a May 2026 global consensus rename involving more than 50 medical organisations. The androgen-sebum mechanism described here did not change — only the name did — and this article uses PCOS since that is still what most readers search.

Your next step

Work out which state you actually have before choosing a routine: oily and dehydrated need different approaches, and a routine built for the wrong one explains a lot of “nothing works for my skin” frustration. If your skin type changed after starting a hormonal treatment, that is very likely the mechanism, not a new problem to solve on top of it — and if oiliness or acne is not responding to topical products at all, that is the signal to discuss the androgen-lowering options above rather than to keep changing skincare.